The prevalence of MTHFR 677C→T missense mutation, total plasma homocysteine levels and associated risk factors in Malay subjects

Medical Journal of Malaysia

Volumn 58, Issue 2, 2003, Pages 243-254

  Ling, King Hwa ^a   Rosli, R ^a   Duraisamy, G ^a   Nasir, M T Mohd ^a  

^a Universiti Putra Malaysia   (Malaysia)

Author keywords

Bioecogenetics; Homocysteine; Methylenetetrahydrofolate reductase; MTHFR 677C T

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTEINE;

ADULT; AGE DISTRIBUTION; AMINO ACID BLOOD LEVEL; ARTICLE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MISSENSE MUTATION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SMOKING; VITAMIN SUPPLEMENTATION;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALAYSIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION, MISSENSE; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; REFERENCE VALUES; RISK FACTORS;

EID: 0141670705     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Moustapha, A, and Robinson, K. Homocysteine: An emerging age-related cardiovascular risk factor. Geriatrics 1999; 54(April): 49-63.
2. Christopher, K, and Van Holde, KE. Biochemistry (2nd ed.) Menlo Park, California. The Benjamin/ Cummings Publishing Company, Inc., 1996.
3. Van Bockxmeer, FM, Mamotte, CD, Vasikaran, SD, and Taylor, RR. The Role of Genetics in Homocysteine Levels. Circulation 1997; 95(1): 21-3.
4. Frosst, P, Blom, HJ, Milos, R, Goyette, P, Sheppard, CA, Mathews, RG, Boers, GHJ, DenHeijer, M, Kluijtmans, LAJ, VandenHeuvel, LP, Rozen, R. Identification of a candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995; 10: 111-3.
5. Killian, R, Tan, KS, and Ian, MG. Homocysteine In: Uri, G, Ulf, dF, Kare B. Genetic factors in coronary heart disease. London. Kluwer Academic Publishers 1994; 139-52.
6. Chen, J, Meir, JS, Jing, M, Jacob, S, Malinow, MR, Charles, HH, and David, JH. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis 2001; 154: 667-72.
7. Saw, SM, Yuan, JM, Ong, CN, Kazuko, A, Lee, HP, Gerhard AC, Mimi CY. Genetic, dietary and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore. Am J Clin Nutr. 2001; 73: 232-9.
8. Wang, XL, Natalia, D, Hua, C, Tetsuo, A, Sim, AS, Greg, C, and David, ELW. Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital - based population. Atherosclerosis 1999; 146: 133-40.
9. Heil, SG, Karin, JAL, Godfried, HB, Petra, V, Martin, dH, Frans, JMT, and Henk, JB. Betaine-Homocysteine Methyltranferases (BHMT): Genomic Sequencing and Relevance to Hyperhomocysteinemia and Vascular Disease in Humans. Molecular Genetics and Metabolism 2000; 71: 511-9.
10. Hermann, W, Quast, S, Ullrich, M, Schultze, H, Bodis, M, and Geisel, J. Hyperhomocysteinemia in high-aged subjects: relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation. Atherosclerosis 1999; 144: 91-101.
11. Fukagawa, NK, Julie, MM, Alexander, W, Amy, HP, David, E, and Bruce, OR. Sex-related differences in methionine metabolism and plasma homocysteine concentrations. Am J Clin Nutr. 2000; 72: 22-9.
12. Ho, CH. The influence of age, sex, vitamin B12, folate levels and methylenetetrahydrofolate reductase C667T genetic mutations on plasma homocysteine in Chinese population. Hematologica 2000; 85: 1051-4.
13. Gale, CR, Hazel, A, Nirree, JP, Stuart, JM, James, RB, and Christopher, NM. Renal function, plasma homocysteine and carotid atherosclerosis in elderly people. Atherosclerosis 2001; 154: 141-6.
14. Hak, AE, Kees, HP, Iris, CDW, Cornelis, J, Albert, H, Jacqueline, CMW, and Coen, DAS. Increased plasma homocysteine after menopause. Atherosclerosis 2000; 149: 163-8.
15. Markus, PS, Stefan, J, Johannes, J, Karl, JL, and Roland, ES. Mildly elevated homocysteine concentrations impair endothelium dependent vasodilation in hypercholesterolemic patients. Atherosclerosis 2000; 153: 383-9.
16. Refsum, H, and Ueland, PM. Clinical significance of pharmacological modulation of homocysteine metabolism. TIPS. 1990; 11: 411-6.
17. Stein, EV, Ottar, N, Helga, R, and Ueland, PM. Coffee and homocysteine [editorial]. Am J Clin Nutr. 2000; 71: 403-4.
18. Lee, BH, Hae, IC, Yoon, SS, Cho, BK, and Wang, KC. The effect of C677T mutation of methylene tetrahydrofolate reductase gene and plasma folate level on hyperhomocysteinemia in patients with meningomyelocele. Child's Nerv Syst. 2000; 16: 559-63.
19. Christine, FS, Martyn, TS, Eleanor, K, Eve, R, Sara, R, Raymond, AC, and Gareth, M. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. PNAS. 1999; 96(2): 12810-15.
20. Ming, Z, Hisahide, N, and Myeong, JL. The C677T mutation in the methylene tetrahydrofolate reductase gene increases serum uric acid in elderly men. J Hum Genet. 2000; 45: 257-62.
21. Ramon, DA. Hyperhomocysteinemia: A New Risk Factor for Alzheimer Disease? Arch Neurol. 1998; 55(Nov): 1407-8.
22. Chee, SS, Zawiah, H, Ismail, MN, and Ng, KK. Anthropometry, dietary patterns and nutrient intakes of Malaysian estate workers. Malaysian Journal of Nutrition 1996; 2: 112-26.
23. Sallis, JF, Haskell, WL, and Wood, PD. Physical activity assessment methodology in the five-city project. American Journal of Epidemiology 1985; 121: 90-109.
24. Lorenzo, DB, and Quanhe, Y. Methylenetetrahydrofolate reductase (MTHFR) and birth defects. Am J Epidemiol. 2000; 151(9): 862-877.
25. Nishio, H, Lee, MJ, Fujii, M, et al. A common mutation in methylenetetrahydrofolate reductase gene among the Japanese population. Jpn J Hum Genet. 1996; 41: 247-51.
26. Arinami, T, Yamada, N, Yamakawa-Kobayashi, K, Hamaguchi, H, and Toru, M. Methylenetetrahydrofolate reductase variant and schizophrenia or depression. Am J Med Genet. 1997; 74: 526-8.
27. Morita, H, Taguchi, J, Kurihara, H, et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 1997; 95: 2032-6.
28. Sohda, S, Arinami, T, Hamada, H, Yamada, N, Hamaguchi, H, and Kubo, T. Methylenetetrahydrofolate reductase polymorphism and preeclampsia. J Med Genet. 1997; 34: 525-6.
29. Nakata, Y, Katsuya, T, Takami, S, et al. Methylenetetrahydrofolate reductase gene polymorphism: relation to blood pressure and cerebrovascular disease. Am J Hypertens. 1998; 11: 1019-23.
30. Ou, T, Yamakawa-Kobayashi, K, Arinami, T, et al. Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study. Atherosclerosis 1998; 137: 23-8.
31. Neugebauer, S, Baba, T, and Watanabe, T. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients [letter]. Lancet 1998; 352: 454.
32. Shaw, GM, Rozen, R, Finnell, RH, Wasserman, CR, and Lammer, EJ. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am J Epidemiol. 1998; 148: 30-7.
33. Mornet, E, Muller, F, and Lenvoise-Furet, A. Screening of the C677T mutation on 5,10-methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet. 1997; 100: 512-4.
34. Kostulas, K, Crisby, M, and Huang, WX. A methylenetetrahydrofolate reductase gene polymorphism in ischaemic stroke and in carotid artery stenosis. Eur J Clin Invest. 1998; 28: 285-9.
35. Koch, MC, Stegmann, K, Ziegler, A, Schroter, B, and Ermert, A. Evaluation of the MTHFR C677T allele and MTHFR gene locus in a German spina bifida population. Eur J Pediatr. 1998; 157: 487-92.
36. Bjorke-Monsen, AL, Ueland, PM, Schneede, J, Vollset, SE, and Refsum, H. Elevated plasma total homocysteine and C677T mutation of the methylenetetrahydofolate reductase gene in patients with spina bifida. QJM. 1997; 90: 593-596.
37. Matsushita, S, Muramatsu, T, Arai, H, Matsui, T, and Higuchi, S. The frequency of the methylenetetrahydro folate reductase-gene mutation varies with age in the normal population [letter]. Am J Hum Genet. 1997; 61: 1459-60.
38. Laurence, FD, Isabelle, Q, Jean, FC, Oxana, G, Muriel, L, Helene, B, Jacqueline, Z, Pieere, K, and Daniel, C. Methylenetetrahydrofolate Reductase Thermolabile Variant and Human Longevity [letter]. Am J Hum Genet. 1997; 60: 999-1001.
39. Astrid, MT, Engbersen, Diana, GF, Godfried, HJB, Erik, MBS, Frans, JMT, and Henk, JB. Thermolabile 5,10-methylenetetrahydrofolate Reductase as a Cause of Mild Hyperhomocysteinemia. Am J Hum Genet. 1995; 56: 142-50.
40. Haller, J. The vitamin status and its adequacy in the elderly: an international overview. Int J Vitamin & Nutrition Res. 1999; 69: 1916-9.
41. Ueland, PM, Steinar, H, Jom, S, Helga, R, and Stein, EV. Biological and clinical implications of the MTHFR C677T polymorphism. Pharmacological Sciences 2001; 22(4): 195-201.
42. Lone, BR, Lars, O, Inge, B, Nils, K, Peter, L, and Hans, P. Folate intake, lifestyle factors, and homocysteine concentrations in younger and older women. Am J Clin Nutr. 2000; 72: 1156-63.
43. Haynes, WG. Homocysteine and atherosclerosis: Potential mechanisms and clinical implications. Proc R Coll Physicians Edinb. 2000; 30: 114-22.
44. Brattstrom, L, Landgren, F, Israelsson, B, et al. Lowering blood homocysteine with folic based supplements: meta-analysis of randomized trials (Homocysteine Lowering Trialists' Collaboration). BMJ. 1998; 316: 894-8.